Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure

How to buy IVERIC bio stock | $16.85

Learn how to easily invest in IVERIC bio stock.

IVERIC bio Inc is a biotechnology business based in the US. IVERIC bio shares (ISEE) are listed on the NASDAQ and all prices are listed in US Dollars. IVERIC bio employs 66 staff and has a market cap (total outstanding shares value) of 0.00.

How to buy shares in IVERIC bio

  1. Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ISEE – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

IVERIC bio stock price (NASDAQ: ISEE)

Use our graph to track the performance of ISEE stocks over time.

IVERIC bio shares at a glance

Information last updated 2021-10-17.
Latest market close$16.85
52-week range$4.96 - $18.07
50-day moving average $14.80
200-day moving average $9.32
Wall St. target price$22.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-1.16

Buy IVERIC bio shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Asset types Option trade fee Annual fee Signup bonus
Stocks, Options, ETFs, Cryptocurrency
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
J.P. Morgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract
Vanguard Personal Advisor
Stocks, Options, Mutual funds, ETFs
$20 per year
Financial advice powered by relationships, not commissions.
Stocks, Bonds, Options, Mutual funds, ETFs, Cryptocurrency
$0 + $0.50/contract
$0 per month
Deposit qualifying assets of $5,000+
A platform built for all kinds of traders and all styles of trading
Sofi Invest
Stocks, ETFs, Cryptocurrency
Get one free stock worth up to $1,000
Open an account
A free way to invest in stocks, ETFs and crypto.
$0 per year
Get a free stock valued up to $350
Open your Futu brokerage account via Moomoo
Trade stocks on the US, Hong Kong, Shanghai and Shenzhen markets.

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy IVERIC bio stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

IVERIC bio price performance over time

Historical closes compared with the close of $16.85 from 2021-10-22

1 week (2021-10-15) -1.63%
1 month (2021-09-23) 3.82%
3 months (2021-07-23) 88.27%
6 months (2021-04-23) 167.04%
1 year (2020-10-23) 180.83%
2 years (2019-10-23) 1,684.20%
3 years (2018-10-23) 652.23%
5 years (2016-10-21) 36.12

IVERIC bio financials

Gross profit TTM $-62,784,000
Return on assets TTM -32.5%
Return on equity TTM -57.11%
Profit margin 0%
Book value $1.54
Market capitalisation $1.8 billion

TTM: trailing 12 months

Shorting IVERIC bio shares

There are currently 13.5 million IVERIC bio shares held short by investors – that's known as IVERIC bio's "short interest". This figure is 9.7% up from 12.3 million last month.

There are a few different ways that this level of interest in shorting IVERIC bio shares can be evaluated.

IVERIC bio's "short interest ratio" (SIR)

IVERIC bio's "short interest ratio" (SIR) is the quantity of IVERIC bio shares currently shorted divided by the average quantity of IVERIC bio shares traded daily (recently around 11.7 million). IVERIC bio's SIR currently stands at 1.16. In other words for every 100,000 IVERIC bio shares traded daily on the market, roughly 1160 shares are currently held short.

However IVERIC bio's short interest can also be evaluated against the total number of IVERIC bio shares, or, against the total number of tradable IVERIC bio shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case IVERIC bio's short interest could be expressed as 0.13% of the outstanding shares (for every 100,000 IVERIC bio shares in existence, roughly 130 shares are currently held short) or 0.1727% of the tradable shares (for every 100,000 tradable IVERIC bio shares, roughly 173 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against IVERIC bio.

Find out more about how you can short IVERIC bio stock.

IVERIC bio share dividends

We're not expecting IVERIC bio to pay a dividend over the next 12 months.

IVERIC bio share price volatility

Over the last 12 months, IVERIC bio's shares have ranged in value from as little as $4.9601 up to $18.07. A popular way to gauge a stock's volatility is its "beta".

ISEE.US volatility(beta: 1.32)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while IVERIC bio's is 1.3228. This would suggest that IVERIC bio's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

IVERIC bio overview

IVERIC bio, Inc. , a biopharmaceutical company, develops novel therapies to treat ophthalmic diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company is developing Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 clinical trial for the treatment of geographic atrophy (GA) secondary to dry age-related macular degeneration (AMD). It is also developing STAR or OPH2005 that is in Phase 2b clinical trial for the treatment of leber congenital amaurosis type 10 (LCA10) and autosomal recessive stargardt disease (STGD1); IC-500, a high temperature requirement A serine peptidase 1 protein inhibitors for the treatment of GA and other age-related retinal diseases; IC-100 for the treatment of rhodopsin-mediated autosomal dominant retinitis pigmentosa; and IC-200 for the treatment of IRDs associated with mutations in the BEST1 gene. In addition, the company develops OPH2001 that has completed Phase 1/2a clinical trial of various doses of Zimura monotherapy for the treatment of GA; OPH2000, which has completed Phase 1/2a clinical trial of various doses of Zimura administered in combination with Lucentis for the treatment of wet AMD; OPH2007 that has completed Phase 2a clinical trial for the treatment of wet AMD; and OPH2002, which has completed Phase 2a clinical trial for the treatment of idiopathic polypoidal choroidal vasculopathy. Its discovery and research programs include miniCEP290 program for LCA10; miniABCA4 Program for STGD1; and miniUSH2A Program for usher syndrome type 2A-Related IRDs. The company was formerly known as Ophthotech Corporation and changed its name to IVERIC bio, Inc.

Frequently asked questions

What percentage of IVERIC bio is owned by insiders or institutions?
Currently 0.739% of IVERIC bio shares are held by insiders and 86.262% by institutions.
How many people work for IVERIC bio?
Latest data suggests 66 work at IVERIC bio.
When does the fiscal year end for IVERIC bio?
IVERIC bio's fiscal year ends in December.
Where is IVERIC bio based?
IVERIC bio's address is: Five Penn Plaza, New York, NY, United States, 10001
What is IVERIC bio's ISIN number?
IVERIC bio's international securities identification number is: US46583P1021
What is IVERIC bio's CUSIP number?
IVERIC bio's Committee on Uniform Securities Identification Procedures number is: 46583P102

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site